| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cifra de Afaceri - Ron | 1.486.340 | 1.325.647 | 647.550 | 526.769 | 429.187 | 272.966 | 263.734 | 95.505 | 25.784 | 161.961 |
| Venituri Totale - Ron | 1.565.225 | 1.520.198 | 673.616 | 531.357 | 442.567 | 275.575 | 267.427 | 96.916 | 26.468 | 162.512 |
| Cheltuieli Totale - Ron | 1.663.153 | 1.437.322 | 707.768 | -196.461 | 246.311 | 159.736 | 194.606 | 185.070 | 195.646 | 182.862 |
| Profit/Pierdere Brut - Ron | -97.928 | 82.876 | -34.152 | 727.818 | 196.256 | 115.839 | 72.821 | -88.154 | -169.178 | -20.350 |
| Profit/Pierdere Net - Ron | -97.928 | 82.876 | -40.266 | 717.991 | 191.908 | 113.260 | 70.228 | -89.090 | -169.431 | -30.242 |
| Salariati | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Verifica rapoartele financiare pentru firma - Pharma Development Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Active Imobilizate | 133.689 | 70.263 | 6.990 | 6.996 | 7.169 | 7.897 | 11.181 | 5.463 | 2.316 | 766 |
| Active Circulante | 558.080 | 556.344 | 378.408 | 646.746 | 320.497 | 440.077 | 323.321 | 297.055 | 338.067 | 417.561 |
| Stocuri | 0 | 0 | 0 | 0 | 0 | 8.100 | 8.280 | 8.100 | 8.100 | 8.100 |
| Creante | 268.953 | 188.144 | 220.323 | 274.752 | 276.180 | 269.113 | 261.275 | 280.530 | 304.182 | 402.567 |
| Casa si conturi | 289.127 | 368.200 | 158.085 | 371.994 | 44.317 | 162.864 | 53.766 | 8.425 | 25.785 | 6.894 |
| Capitaluri Proprii | -125.042 | -42.166 | -81.432 | 636.568 | 288.904 | 402.164 | 291.121 | 202.031 | 32.600 | 2.358 |
| Capital Social | 1.000 | 1.000 | 2.000 | 2.010 | 2.020 | 2.020 | 2.020 | 2.020 | 2.020 | 2.020 |
| Datorii | 817.592 | 669.477 | 469.628 | 17.401 | 38.762 | 45.810 | 43.474 | 100.509 | 307.783 | 419.357 |
| Venituri in Avans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| CAEN Principal | "4619 - 4619" | |||||||||
| CAEN An Financiar |
4619
|
|||||||||
Comentarii - Pharma Development Srl